Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
XPLR Infrastructure (XIFR) trades at a steep discount to book and carries heavy leverage and negative trailing free cash flow. That creates a binary, event-driven opportunity: if management elects asset monetization, debt restructuring, or a settlement that crystallizes value, equity holders could see a special distribution equivalent to 60-70% of …
The Bank of England's Monetary Policy Committee voted 6-3 to maintain Bank Rate at 3.75%, with three members preferring a rise to 4% as renewed conflict between the United States and Iran lifted risks to energy markets. Governor Andrew Bailey and the majority of the MPC continued a wait-and-see strategy aimed at preventing inflation from drifting s…
CCC Intelligent Solutions Holdings Inc. announced its Q2 2026 financial results showing nearly 10% revenue growth and significant increases in adjusted EBITDA and net income. The company emphasized expanding adoption of its AI-powered insurance solutions among top insurers and repair operators. Financial guidance for Q3 and full year 2026 reflects …
Qualcomm said it expects near-term profit margins to face headwinds as memory, wafer and testing costs rise amid an AI-driven surge in data-center spending. The company forecast adjusted earnings per share below consensus for the quarter and signaled a materially smaller modem share in the next iPhone than its earlier 20% projection. Management exp…
Yum Brands reported quarterly adjusted EPS of $1.62 and comparable sales growth driven by a 7% rise at Taco Bell, but the company is confronting a widespread cyclospora outbreak linked to its Taco Bell chain that has depressed foot traffic and left investors cautious ahead of executive commentary on results.
Situational Awareness LP, run by former OpenAI researcher Leopold Aschenbrenner, has approached existing investors and lenders for additional capital after losses tied to a July 2026 selloff in AI-related stocks. The fund, which had posted a strong 2026 gain through June, holds concentrated long positions in AI infrastructure and sizable put exposu…
Rocket Lab's stock rose after the company announced a new multi-launch agreement with Institute for Q-shu Pioneers of Space (iQPS) covering three dedicated Electron missions. The contract increases iQPS's booked launches with Rocket Lab to 18 and includes the purchase of Rocket Lab's Motorized Lightband separation system. The missions, each carryin…
Microsoft reported strong Q4 2026 results (revenue $90B, operating income $40.6B) and left its $175B annual capex plan intact. Datacenter assets deliver decades of revenue tailwinds even as the accelerators inside are refreshed every few years. Take a controlled long position: the cloud cash machine supports buybacks and margins even if the chip cy…
EyePoint, Inc. has successfully completed enrollment of over 480 patients in its global Phase 3 COMO and CAPRI trials evaluating DURAVYU™ (vorolanib intravitreal insert) for diabetic macular edema (DME). Enrollment finished ahead of schedule within five months, reflecting strong interest among the retinal specialist community. DURAVYU is a sustaine…
Huntington Ingalls Industries (NYSE: HII) reported robust second quarter 2026 results with revenues rising 10.9% year-over-year to $3.4 billion and net earnings increasing by 36.8% to $208 million ($5.27 diluted EPS). The company raised its full-year 2026 shipbuilding revenue guidance to $10.2-$10.4 billion and improved the lower end of the shipbui…
Madrigal Pharmaceuticals reported a strong second quarter of 2026 with net sales of Rezdiffra reaching $364.3 million, a 71% year-over-year increase. The company highlighted exceeding 50,000 active patients on the drug, reinforced its intellectual property portfolio with new patents extending protections to 2042-2045, and advanced its oral GLP-1 ca…
LKQ Corporation reported second quarter 2026 results showing a 3% revenue decline to $3.4 billion, with net income and adjusted net income decreasing compared to prior year. North America segment achieved positive organic growth driven by increased alternative parts usage, while Europe underperformed due to ERP implementation issues. The company co…
AMC Global Media Inc. reported its Q2 2026 financial results, emphasizing a new global co-exclusive content licensing agreement with Netflix for the streaming rights to the entire Walking Dead Universe, generating $500 million over five years. While the company renewed key distribution agreements and increased full-year guidance, Q2 revenues declin…
Mangoceuticals, Inc. has entered into a business combination agreement with Nuclea Energy Inc., a Canadian advanced nuclear technology firm developing the Morpheus lead-cooled microreactor. The transaction will bring Nuclea public via Mangoceuticals’ Nasdaq listing, supporting Nuclea's advancement toward commercialization amid growing electricity d…
Beyond Air, a NASDAQ-listed commercial-stage medical device and biopharmaceutical company, announced a private placement offering of up to $30.1 million at-the-market under Nasdaq rules. The financing involves the sale of common stock, pre-funded warrants, and accompanying Series A and B warrants to institutional healthcare investors and company in…
HUTCHMED reported robust growth in China product sales led by ELUNATE® and SULANDA®, with over 40% sales increase, and strong ex-US sales growth for FRUZAQLA®. The company maintained profitability with $15.9 million net income amid higher R&D investment and a strong cash position of $1.37 billion. Multiple first-in-class Antibody-Targeted Therapy C…
Allegro MicroSystems, Inc. announced its financial results for the first quarter of fiscal 2027, showing strong momentum with $259 million in sales, a 27% year-over-year increase. The company returned to profitability with GAAP EPS of $0.08 compared to a loss the prior year, and non-GAAP EPS grew over 2.5 times to $0.23. Growth was led by data cent…
Shoals Technologies Group, a Nasdaq-listed leader in electrical infrastructure for the energy transition market, announced its participation in several upcoming virtual and in-person investor events hosted by prominent financial institutions between August and October 2026. These events will involve fireside chats, conferences, and roadshows focuse…
Colliers International Group Inc. announced robust second quarter 2026 financial results, showing a 17% increase in consolidated revenues to $1.57 billion and a 14% rise in Adjusted EBITDA to $205.3 million compared to Q2 2025. Adjusted EPS increased 6% to $1.83. The company's diversified business model continues to fuel growth across Commercial Re…
Wrap Technologies, Inc. announced that Stark Security Inc. will deploy WRAP's immersive virtual reality training platform, Wrap Reality, for officer training across multiple Midwest states. This strategic move marks WRAP's deeper expansion into the private security market, leveraging VR training to improve decision-making, de-escalation, and risk r…
Codere Online reported record second quarter financial results with net gaming revenue up 27% year-over-year to €69.4 million and Adjusted EBITDA more than doubling to €5.8 million. The company saw strong growth in its core markets of Spain and Mexico, driven in part by heightened betting activity during the World Cup. With a cash position of €62.6…
Ultralife Corporation (NASDAQ: ULBI) announced it will release its second quarter 2026 financial results on August 7, 2026, before the market opens, followed by an investor conference call and webcast. The company specializes in power solutions and communication systems serving government, defense, and commercial sectors globally.
INmune Bio has established a Scientific Advisory Board composed of global experts to support the late-stage clinical and regulatory development of Ebstrocel, a treatment for recessive dystrophic epidermolysis bullosa (RDEB), and to guide expansion of its proprietary CORDStrom™ mesenchymal stromal cell platform into new therapeutic areas. The SAB wi…
Immunocore Holdings plc announced that it will release its financial results for the second quarter of 2026 on August 6, 2026, followed by a live webcast and conference call to discuss the results and provide updates on its business and portfolio. The company is a commercial-stage biotech focused on novel immunotherapies targeting cancer, infectiou…
Bristol Myers Squibb reported second-quarter revenue and adjusted earnings that beat analyst expectations, prompting the company to raise its full-year revenue guidance and increase its 2026 adjusted earnings forecast. Powerful sales of the blood thinner Eliquis and several recently launched medicines - including Camzyos, Reblozyl and Breyanzi - un…
